Ovid Therapeutics
OVID
#9224
Rank
A$0.10 B
Marketcap
$1.52
Share price
-4.94%
Change (1 day)
-69.44%
Change (1 year)

Earnings for Ovid Therapeutics (OVID)

Earnings in 2024 (TTM): -A$47.95 Million

According to Ovid Therapeutics 's latest financial reports the company's current earnings are A$0.63 Million. In 2023 the company made an earning of -A$83.95 Million, an increase over its 2022 earnings that were of -A$86.8 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Ovid Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$47.95 Million-42.88%
2023 -A$83.95 Million-3.29%
2022 -A$86.8 Million-143.59%
2021 A$0.19 B-253.22%
2020 -A$0.13 Billion34.03%
2019 -A$96.97 Million16.32%
2018 -A$83.37 Million-19.79%
2017 -A$0.11 Billion189.13%
2016 -A$35.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion 314.61%๐Ÿ‡บ๐Ÿ‡ธ USA